
Gliman M 3mg/500mg Tablet SR
Marketer
Aman Healthcare
Salt Composition
Glimepiride (3mg) + Metformin (500mg)
Overview Gliman M 3mg/500mg Tablet SR
Diabex Duo 3mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical guidance can elevate blood sugar, risking complications like kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan, including dietary adjustments, regular physical activity, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Prompt glucose intake (e.g., sugary foods or juice) is essential. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal dysfunction. Individuals with a history of heart disease should consult their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.
Primary Ingredients of Gliman M 3mg/500mg Tablet SR
No text provided. Please provide the text you want me to rephrase.
Uses of Gliman M 3mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Gliman M 3mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gliman M 3mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with food.
Common Side effects of Gliman M 3mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Gliman M 3mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet; avoid chewing, crushing, or breaking it. The Gliman M 3mg/500mg sustained-release tablet should be taken with a meal.
How Gliman M 3mg/500mg Tablet SR works:
Each Gliman M 3mg/500mg sustained-release tablet combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Gliman M 3mg/500mg SR tablets is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Gliman M 3mg/500mg tablet might pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers before prescribing it. Consult your physician for advice.
Breast feedingUNSAFE
Prolonged-release Gliman M 3mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience such symptoms.
KidneyCAUTION
Patients with kidney impairment should use Gliman M 3mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Gliman M 3mg/500mg SR tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Gliman M 3mg/500mg SR tablets. Dosage modification may be necessary. Consult a physician for guidance. A low initial dose of Gliman M 3mg/500mg SR tablets is typically recommended for individuals with mild to moderate hepatic dysfunction; however, its administration is contraindicated in those with severe liver disease.
What if you forget to take Gliman M 3mg/500mg Tablet SR :
Should you forget to take a Gliman M 3mg/500mg SR tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gliman M 3mg/500mg Tablet SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Medication for diabetes |
